{"source":"Breaknorm","page":"https://breaknorm.co/company/imux.com","license":"https://breaknorm.co/terms","domain":"imux.com","name":"Immunic Therapeutics","legal_name":"Immunic Therapeutics","country":"DE","country_second":"US","city":"New York","admin1":"New York","vertical":"manufacturing_industry","subvertical":"supplement_and_cosmetics_manufacturing","leaf":"pharmaceutical_manufacturers","summary":"Immunic Therapeutics is a late-stage biotechnology company that develops selective oral drugs in immunology for neurologic diseases. Its pipeline includes Vidofludimus Calcium and IMU-856, oral treatments for multiple sclerosis and celiac disease. The company is in clinical development with programs addressing chronic inflammatory and autoimmune conditions.","offerings":["vidofludimus calcium","imu-856","imu-381"],"target_customers":["multiple sclerosis patients","celiac disease patients","patients with multiple sclerosis","patients with celiac disease","investors and stakeholders"],"business_model":["B2C","B2B"],"geo_scope":"unknown","headcount":"51-200","headcount_source":"linkedin","revenue":"50M-250M","revenue_source":"estimated","certifications":[],"langs":["en"],"linkedin":"https://www.linkedin.com/company/immunic-therapeutics","reviews":[],"contact_points":1,"contact_phones":3,"page_types":["privacy","pricing","home","imprint","contact","careers"],"crawled":"2026-08-07","profiled":"2026-08-16","indexed":"2026-10-02","hiring_built":"2026-10-27","website_tech":["matomo","1password","atlassian","docker","eqs_group","jamf","mailjet","microsoft_365","microsoft_teams","offensity","perplexity","retarus","tresorit"],"hiring":{"open":13,"open_postings":13,"new_7d":1,"new_30d":7,"new_90d":13,"closed_30d":0,"countries":["DE","US"]},"hiring_functions":[["marketing_and_communications",4,3],["research_and_science",3,1],["human_resources",1,1],["product_program_and_project_management",1,1],["quality_safety_and_environment",1,0]],"tech_jobs":[],"intents":[{"predicate":"launching","function":"","posting_id":5453,"title":"Vice President, Market Access","date":"2026-08-17","quote":"Market Access organization as we prepare for the anticipated launch of vidofludimus calcium for the treatment of relapsing multiple sclerosis (RMS)."},{"predicate":"launching","function":"","posting_id":5462,"title":"Senior Director/VP - HR","date":"2026-10-11","quote":"You will join us at a pivotal moment as we enter our next chapter and its evolution as we prepare for commercial launch in the US."}],"recent_postings":[{"id":11813255,"title":"Associate Director, GMP Quality Assurance","city":"United States","function":"quality_safety_and_environment","family":"quality_safety_and_environment/quality_assurance_and_management","seniority":"director","posted":"2026-10-31","url":"https://jobs.ashbyhq.com/immunic-therapeutics/a42c0ed4-f3bd-4e53-93b1-1a7ae3aeb22a","tech":[]},{"id":11813256,"title":"Associate Director/Director, Quality Management Systems (QMS)","city":"United States","function":"quality_safety_and_environment","family":"quality_safety_and_environment/quality_assurance_and_management","seniority":"director","posted":"2026-10-30","url":"https://jobs.ashbyhq.com/immunic-therapeutics/7c01c46a-1bee-4799-93d6-f1c11b6601d4","tech":[]},{"id":5463,"title":"Senior Director/VP – Translational Medicine & Pharmacology","city":"United States","function":"research_and_science","family":"research_and_science/clinical_research_and_medical_affairs","seniority":"vp","posted":"2026-10-19","url":"https://jobs.ashbyhq.com/immunic-therapeutics/f24edfca-5ae7-4048-a98d-c258c829903e","tech":[]},{"id":5464,"title":"Associate Director/Director Project Management","city":"United States","function":"product_program_and_project_management","family":"product_program_and_project_management/project_management","seniority":"director","posted":"2026-10-19","url":"https://jobs.ashbyhq.com/immunic-therapeutics/3364ff3b-f52d-4665-92da-26d1b19aec94","tech":[]},{"id":5462,"title":"Senior Director/VP - HR","city":"Gräfelfing","function":"human_resources","family":"human_resources/hr_generalist_and_business_partnering","seniority":"vp","posted":"2026-10-11","url":"https://jobs.ashbyhq.com/immunic-therapeutics/d540b027-b42b-4295-911b-c4e180d98544","tech":[]},{"id":5461,"title":"Senior Director, Project Management & Operational Excellence","city":"Gräfelfing","function":"","family":null,"seniority":"director","posted":"2026-10-11","url":"https://jobs.ashbyhq.com/immunic-therapeutics/32020094-3e7d-4b70-a2e6-d39c1d754f7d","tech":[]},{"id":5460,"title":"Director/Senior Director, Communications","city":"United States","function":"marketing_and_communications","family":"marketing_and_communications/communications_and_pr","seniority":"director","posted":"2026-10-01","url":"https://jobs.ashbyhq.com/immunic-therapeutics/5d243a9b-5366-4eff-ab79-ed7ee64051bb","tech":[]},{"id":5459,"title":"Vice President, Patient Advocacy & Corporate Communications","city":"United States","function":"marketing_and_communications","family":"marketing_and_communications/communications_and_pr","seniority":"vp","posted":"2026-10-01","url":"https://jobs.ashbyhq.com/immunic-therapeutics/36875de3-a5af-469b-aaa6-94de7c02f056","tech":[]}],"ats":"Ashby","similar":[{"domain":"panzygausa.com","name":"Panzyga®","country":"US","city":"Paramus","headcount":"51-200","leaf":"pharmaceutical_manufacturers","summary":"Panzyga® is a manufacturer of immune globulin intravenous (IVIG) that treats chronic inflammatory demyelinating polyneuropathy (CIDP), chronic immune thrombocyt."},{"domain":"highcloutpharma.com","name":"High Clout Pharma Limited","country":"NG","city":"Mushin","headcount":"51-200","leaf":"pharmaceutical_wholesale","summary":"High Clout Pharma Limited is a pharmaceutical distributor that markets and distributes pharmaceutical products."},{"domain":"nufactor.com","name":"Nufactor","country":"US","city":"Temecula","headcount":"51-200","leaf":"pharmaceutical_manufacturers","summary":"Nufactor is a specialty pharmacy and home infusion service that provides individualized patient care for patients with rare diseases and bleeding disorders."},{"domain":"immuneonco.com","name":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc.","country":"US","city":null,"headcount":"51-200","leaf":"pharmaceutical_manufacturers","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc."},{"domain":"celltrionhealthcare.de","name":"Celltrion Healthcare","country":"DE","city":"Tower of London","headcount":"51-200","leaf":"pharmaceutical_manufacturers","summary":"Celltrion Healthcare is a biologic/biosimilar pharmaceutical company that develops and supplies biologics to patients worldwide."},{"domain":"entyvio.com","name":"ENTYVIO","country":"US","city":null,"headcount":"2-10","leaf":"pharmaceutical_manufacturers","summary":"ENTYVIO is a biologic drug treatment for Crohn's disease and ulcerative colitis that blocks inflammation-causing cells from entering the gut."}],"similar_scored":589,"customers":null,"as_of":"2026-11-02","updated_at":"2026-11-02","hash":"46de1e229e3ee1ff","index_tier":1}